Abstract
We evaluated the potential association between plasma high-mobility group box 1 (HMGB1) levels and outcome in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention.
| Original language | English |
|---|---|
| Journal | J A C C: Cardiovascular Interventions |
| Volume | 4 |
| Issue number | 3 |
| Pages (from-to) | 281-6 |
| Number of pages | 6 |
| ISSN | 1936-8798 |
| DOIs | |
| Publication status | Published - 2011 |
| Externally published | Yes |
Keywords
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary
- Biological Markers
- Case-Control Studies
- Chi-Square Distribution
- Denmark
- Enzyme-Linked Immunosorbent Assay
- Female
- HMGB1 Protein
- Humans
- Linear Models
- Logistic Models
- Male
- Middle Aged
- Myocardial Infarction
- Predictive Value of Tests
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Up-Regulation
Fingerprint
Dive into the research topics of 'Plasma high-mobility group box 1 levels predict mortality after ST-segment elevation myocardial infarction'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS